Evidence Based Deprescribing Guideline Symposium 2018
Monday, March 26th – Wednesday, March 28th 2018
Ottawa Conference and Event Centre, 200 Coventry Road, Ottawa, Ontario Canada
The Bruyere Deprescribing Guidelines Research Team is hosting the Evidence Based Deprescribing Guideline Symposium 2018, March 26-28, 2018 in Ottawa, Canada. The symposium centers on sharing experiences and building momentum for deprescribing guideline development, implementation, education and research, allowing attendees to interact with high-quality content, network with colleagues and discover innovative developments in deprescribing guideline use.
Monday, March 26, 2018
Focus: Developing GRADE evidence- based deprescribing guidelines
Target audience: Current clinical guideline developers and people interested in developing deprescribing recommendations
Tuesday, March 27, 2018
Focus: Implementing evidence-based deprescribing guidelines
Target audience: Health care professionals, policy makers and members of the public interested in implementing deprescribing guidelines
Wednesday, March 28, 2018
Focus: Developing deprescribing guideline curricula; evaluating deprescribing guideline impact
Target audience: Educators and researchers
Access to the Evidence Based Deprescribing Guideline Symposium 2018 Preliminary Agenda
With over 150 participants expected to attend, you will be joined by:
- Educators, policymakers, health providers and senior decision makers in the health care system
- Physicians, pharmacists, nurse practitioners, and other health professionals
- Representatives of patient care groups
Ottawa Conference and Event Centre
200 Coventry Rd, Ottawa, ON Canada K1K 4S3
+1 613 288 3450
How can I contact the organizer with questions?
If you have questions regarding registration or the symposium please email firstname.lastname@example.org
What is the refund policy?
30 days or more before the event – full refund via Event Brite cancellation
Less than 30 days before the event – No refund (transfer to another individual only)
Booking confirmation will be sent to you immediately for all on-line bookings. If you have not received an email confirmation within 24 hours of making the on-line booking, please contact the team at email@example.com
In the News
Barbara Farrell discusses the recently developed antihyperglycemic deprescribing algorithm and guidelines, developed by the BRI Deprescribing Guidelines Research Team with Medscape (Dec 27th,...
Barbara Farrell discusses the ongoing issue of older people taking too many medications and ways to facilitate deprescribing with the Washington Post (Dec 9th,...
Cara Tannenbaum and Barb Farrell discuss CaDeN and ongoing research and initiatives that are helping curb risky prescription drug use among seniors in the Canadian Medical Association Journal (Sept 14th,...
Barb Farrell talks about the deprescribing guidelines and the work of the Bruyère Research Institute and the Canadian Deprescribing Network (CaDeN) in the Ottawa Citizen (Oct. 1st,...
Barb Farrell and colleagues discussed deprescribing on the live program, On Point, on National Public Radio (wbur 90.9, October 18th, 2016)